Dr. Johnnie Hinton Iii, M.D. Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 620 W Grove St, El Dorado, AR 71730 Phone: 501-321-9803 Fax: 501-321-0710 |
Dr. Michael D Schonefeld, M.D. Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 620 W Grove St, El Dorado, AR 71730 Phone: 501-321-9803 Fax: 501-321-0710 |
News Archive
It's been almost two weeks since the Food and Drug Administration missed its deadline to announce the results of a new safety assessment of the toxic plastics chemical bisphenol A, or BPA, and each day more newborn babies and pregnant women are left unprotected from this hormone-disrupting compound linked to breast cancer and birth defects.
Inspired by a naturally occurring material found in marine mussels, researchers at The University of Texas at Austin have created a new flame retardant to replace commercial additives that are often toxic and can accumulate over time in the environment and living animals, including humans.
Data from four pivotal Phase III clinical trials demonstrate that linagliptin achieved statistically significant and sustained reductions in blood sugar as measured by hemoglobin A1c, fasting plasma glucose and postprandial glucose. Boehringer Ingelheim Pharmaceuticals, Inc. is investigating the dipeptidyl peptidase 4 inhibitor as an oral once-daily tablet, as monotherapy and combination therapy, to treat type 2 diabetes.
Canada's investments in drug information systems (DIS) will generate $436 million in cost savings and efficiencies in 2010, announced Richard Alvarez, President and CEO, Canada Health Infoway (Infoway). The findings are outlined in an independent study commissioned by Infoway, released today.
In diseases like cancer, diabetes, rheumatism and stroke, a disorder develops in the blood vessels that exacerbates the condition and obstructs treatment.
› Verified 1 days ago